OM
Insider selling
Opaleye Management Inc. sold $1.1M of Eton Pharmaceuticals, Inc. (ETON) stock
Opaleye Management Inc., 10% owner of Eton Pharmaceuticals, Inc. (ETON), sold 28,315 shares of ETON stock worth $1.1M, per an SEC Form 4 filed Jul 16, 2026.
It was an open-market sale.
The trade happened on Jul 14, 2026, 2 days before it was made public.
ETON has moved +52.2% since the trade date, from $37.51 to $57.09 (Sep 22, 2026 close).
- Traded
- Jul 14, 2026
- Disclosed
- Jul 16, 2026
- Filing delay
- 2 days
- Price since
- +52.2%
- Role
- 10% owner
- Source
- SEC Form 4
More ETON insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.